213 related articles for article (PubMed ID: 24801872)
1. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer.
Xu CH; Yu LK; Hao KK
PLoS One; 2014; 9(5):e96384. PubMed ID: 24801872
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic and prognostic value of serum YKL-40 in endometrial cancer.
Fan JT; Si XH; Liao Y; Shen P
Arch Gynecol Obstet; 2013 Jan; 287(1):111-5. PubMed ID: 22945838
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
4. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer.
Chen C; Zhu YH; Huang JA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S336-S340. PubMed ID: 29970686
[TBL] [Abstract][Full Text] [Related]
6. Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study.
Tarpgaard LS; Guren TK; Glimelius B; Christensen IJ; Pfeiffer P; Kure EH; Sorbye H; Ikdahl T; Yilmaz M; Johansen JS; Tveit KM
PLoS One; 2014; 9(2):e87746. PubMed ID: 24498368
[TBL] [Abstract][Full Text] [Related]
7. High YKL-40 serum concentration is correlated with prognosis of Chinese patients with breast cancer.
Wang D; Zhai B; Hu F; Liu C; Zhao J; Xu J
PLoS One; 2012; 7(12):e51127. PubMed ID: 23227243
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
9. High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer.
Choi IK; Kim YH; Kim JS; Seo JH
Acta Oncol; 2010 Aug; 49(6):861-4. PubMed ID: 20553098
[No Abstract] [Full Text] [Related]
10. CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients.
Shi WL; Li J; Du YJ; Zhu WF; Wu Y; Hu YM; Chen YC
Med Oncol; 2013 Dec; 30(4):755. PubMed ID: 24178178
[TBL] [Abstract][Full Text] [Related]
11. The place of YKL-40 in non-small cell lung cancer.
Kırankaya Güneş A; Gül Ş; Tutar N; Özgül MA; Çetinkaya E; Zengi O; Onaran H
Tuberk Toraks; 2014; 62(4):273-8. PubMed ID: 25581691
[TBL] [Abstract][Full Text] [Related]
12. High serum YKL-40 level in patients with small cell lung cancer is related to early death.
Johansen JS; Drivsholm L; Price PA; Christensen IJ
Lung Cancer; 2004 Dec; 46(3):333-40. PubMed ID: 15541818
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
14. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E
Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116
[TBL] [Abstract][Full Text] [Related]
15. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients.
Liu T; Zhou T; Luo F; Yang Y; Zhao S; Huang Y; Zhao H; Zhang L; Zhao Y
Cancer Control; 2021; 28():10732748211028257. PubMed ID: 34184581
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
[TBL] [Abstract][Full Text] [Related]
19. The Assessment of Clinical Usage and Prognostic Value of YKL-40 Serum Levels in Patients With Rectal Cancer Without Distant Metastasis.
Fuksiewicz M; Kotowicz B; Rutkowski A; Achinger-Kawecka J; Wagrodzki M; Kowalska MM
Technol Cancer Res Treat; 2018 Jan; 17():1533033818765209. PubMed ID: 29642772
[TBL] [Abstract][Full Text] [Related]
20. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
